Cargando…

Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk

Beginning in the late 1990s, a movement began within the pain management field focused upon the underutilization of opioids, thought to be a potentially safe and effective class of pain medication. Concern for addiction and misuse were present at the start of this shift within pain medicine, and an...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Elizabeth, Robinson, Richard C., Noe, Carl E., Van Ness, Olivia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934582/
https://www.ncbi.nlm.nih.gov/pubmed/27417617
http://dx.doi.org/10.3390/healthcare4020029
_version_ 1782441362699845632
author Huber, Elizabeth
Robinson, Richard C.
Noe, Carl E.
Van Ness, Olivia
author_facet Huber, Elizabeth
Robinson, Richard C.
Noe, Carl E.
Van Ness, Olivia
author_sort Huber, Elizabeth
collection PubMed
description Beginning in the late 1990s, a movement began within the pain management field focused upon the underutilization of opioids, thought to be a potentially safe and effective class of pain medication. Concern for addiction and misuse were present at the start of this shift within pain medicine, and an emphasis was placed on developing reliable and valid methods and measures of identifying those at risk for opioid misuse. Since that time, the evidence for the safety and effectiveness of chronic opioid therapy (COT) has not been established. Rather, the harmful, dose-dependent deleterious effects have become clearer, including addiction, increased risk of injuries, respiratory depression, opioid induced hyperalgesia, and death. Still, many individuals on low doses of opioids for long periods of time appear to have good pain control and retain social and occupational functioning. Therefore, we propose that the question, “Who is at risk of opioid misuse?” should evolve to, “Who may benefit from COT?” in light of the current evidence.
format Online
Article
Text
id pubmed-4934582
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-49345822016-07-12 Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk Huber, Elizabeth Robinson, Richard C. Noe, Carl E. Van Ness, Olivia Healthcare (Basel) Review Beginning in the late 1990s, a movement began within the pain management field focused upon the underutilization of opioids, thought to be a potentially safe and effective class of pain medication. Concern for addiction and misuse were present at the start of this shift within pain medicine, and an emphasis was placed on developing reliable and valid methods and measures of identifying those at risk for opioid misuse. Since that time, the evidence for the safety and effectiveness of chronic opioid therapy (COT) has not been established. Rather, the harmful, dose-dependent deleterious effects have become clearer, including addiction, increased risk of injuries, respiratory depression, opioid induced hyperalgesia, and death. Still, many individuals on low doses of opioids for long periods of time appear to have good pain control and retain social and occupational functioning. Therefore, we propose that the question, “Who is at risk of opioid misuse?” should evolve to, “Who may benefit from COT?” in light of the current evidence. MDPI 2016-05-25 /pmc/articles/PMC4934582/ /pubmed/27417617 http://dx.doi.org/10.3390/healthcare4020029 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Huber, Elizabeth
Robinson, Richard C.
Noe, Carl E.
Van Ness, Olivia
Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk
title Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk
title_full Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk
title_fullStr Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk
title_full_unstemmed Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk
title_short Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk
title_sort who benefits from chronic opioid therapy? rethinking the question of opioid misuse risk
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934582/
https://www.ncbi.nlm.nih.gov/pubmed/27417617
http://dx.doi.org/10.3390/healthcare4020029
work_keys_str_mv AT huberelizabeth whobenefitsfromchronicopioidtherapyrethinkingthequestionofopioidmisuserisk
AT robinsonrichardc whobenefitsfromchronicopioidtherapyrethinkingthequestionofopioidmisuserisk
AT noecarle whobenefitsfromchronicopioidtherapyrethinkingthequestionofopioidmisuserisk
AT vannessolivia whobenefitsfromchronicopioidtherapyrethinkingthequestionofopioidmisuserisk